,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny-04', 'love this']
just wow. i love this drug. destiny does it again. results from destiny-04, 6mo improvements in pfs and os. #asco22 
Breast medical oncologist at Levine Cancer Institute @LevineCancer @LCI_YWBP